İlhami Berber

829 total citations
66 papers, 450 citations indexed

About

İlhami Berber is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, İlhami Berber has authored 66 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 18 papers in Genetics and 12 papers in Immunology. Recurrent topics in İlhami Berber's work include Hematopoietic Stem Cell Transplantation (19 papers), Multiple Myeloma Research and Treatments (8 papers) and COVID-19 Clinical Research Studies (8 papers). İlhami Berber is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Multiple Myeloma Research and Treatments (8 papers) and COVID-19 Clinical Research Studies (8 papers). İlhami Berber collaborates with scholars based in Türkiye, Cambodia and Cyprus. İlhami Berber's co-authors include Mehmet Ali Erkurt, Emın Kaya, İrfan Kuku, Mustafa Köroğlu, Mehmet Sinan Dal, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Burhan Turgut, Tuba Hacıbekiroğlu and Serdal Korkmaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Virology and Bone Marrow Transplantation.

In The Last Decade

İlhami Berber

54 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlhami Berber Türkiye 12 189 133 123 65 57 66 450
Mehmet Ali Erkurt Türkiye 15 207 1.1× 183 1.4× 224 1.8× 129 2.0× 107 1.9× 94 731
Zegeye Getaneh Ethiopia 12 91 0.5× 63 0.5× 123 1.0× 26 0.4× 55 1.0× 28 440
Panyang Xu China 4 295 1.6× 78 0.6× 63 0.5× 108 1.7× 9 0.2× 11 412
Ülker Koçak Türkiye 14 102 0.5× 94 0.7× 283 2.3× 37 0.6× 86 1.5× 67 580
Amaylia Oehadian Indonesia 8 330 1.7× 125 0.9× 29 0.2× 158 2.4× 20 0.4× 31 518
Mikhail Menis United States 16 91 0.5× 38 0.3× 183 1.5× 48 0.7× 80 1.4× 30 520
Mehrdad Rostami Iran 8 228 1.2× 63 0.5× 27 0.2× 98 1.5× 12 0.2× 19 359
Cynthia Macahilig United States 14 131 0.7× 88 0.7× 55 0.4× 16 0.2× 29 0.5× 47 637
Marina Loucaidou United Kingdom 10 158 0.8× 89 0.7× 37 0.3× 55 0.8× 10 0.2× 21 509
M. Hanoy France 11 175 0.9× 22 0.2× 35 0.3× 37 0.6× 19 0.3× 25 450

Countries citing papers authored by İlhami Berber

Since Specialization
Citations

This map shows the geographic impact of İlhami Berber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlhami Berber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlhami Berber more than expected).

Fields of papers citing papers by İlhami Berber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlhami Berber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlhami Berber. The network helps show where İlhami Berber may publish in the future.

Co-authorship network of co-authors of İlhami Berber

This figure shows the co-authorship network connecting the top 25 collaborators of İlhami Berber. A scholar is included among the top collaborators of İlhami Berber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlhami Berber. İlhami Berber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erkurt, Mehmet Ali, Si̇nan Demi̇rci̇oğlu, İlhami Berber, et al.. (2025). The role of heparin in autologous stem cell mobilization in patients with multiple myeloma. Transfusion and Apheresis Science. 64(4). 104185–104185.
2.
Berber, İlhami, et al.. (2025). When should I use filgrastim after autologous transplantation in MM patients?. Transfusion and Apheresis Science. 64(4). 104171–104171.
3.
Erkurt, Mehmet Ali, İlhami Berber, Sinem Namdaroğlu, et al.. (2024). Efficacy of Ruxolitinib in the management of chronic GVHD. Transfusion and Apheresis Science. 64(1). 104053–104053. 1 indexed citations
4.
Namdaroğlu, Sinem, Mehmet Ali Erkurt, İlhami Berber, et al.. (2024). The role of ruxolitinib in the management of acute GVHD. Transfusion and Apheresis Science. 64(1). 104055–104055.
5.
Erkurt, Mehmet Ali, et al.. (2023). The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience. SHILAP Revista de lepidopterología. 24(2). 216–220. 1 indexed citations
6.
Erkurt, Mehmet Ali, et al.. (2023). Effect of extracorporeal photopheresis on survival in acute graft versus host disease. Journal of Clinical Apheresis. 38(5). 602–610. 1 indexed citations
7.
Erkurt, Mehmet Ali, et al.. (2023). How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience. Acta Oncologica Turcica. 56(2). 106–113. 1 indexed citations
8.
9.
10.
Erkurt, Mehmet Ali, et al.. (2021). An innovation in stem cell harvesting: Heparin use. Transfusion and Apheresis Science. 60(5). 103240–103240. 2 indexed citations
11.
Erkurt, Mehmet Ali, et al.. (2021). Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients. Transfusion and Apheresis Science. 60(4). 103159–103159. 3 indexed citations
12.
Erkurt, Mehmet Ali, et al.. (2021). The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients. Transfusion and Apheresis Science. 60(5). 103248–103248. 4 indexed citations
13.
Dal, Mehmet Sinan, Mehmet Ali Erkurt, İrfan Kuku, et al.. (2021). Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study. Transfusion and Apheresis Science. 60(5). 103243–103243. 3 indexed citations
14.
Berber, İlhami, Yasir Furkan Çağın, Harika Gözükara Bağ, et al.. (2021). Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis. Transfusion and Apheresis Science. 60(5). 103250–103250. 5 indexed citations
15.
Berber, İlhami, et al.. (2015). A hundred years after the first article, a recollection: Cabot ring. The Korean Journal of Internal Medicine. 31(1). 199–199.
16.
Berber, İlhami, et al.. (2014). As a Rare Disease Bernard–Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura: A Case Report. American Journal of Medical Case Reports. 2(5). 102–106. 2 indexed citations
17.
Berber, İlhami, et al.. (2014). Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report. Transfusion and Apheresis Science. 51(1). 73–76. 1 indexed citations
18.
Erkurt, Mehmet Ali, et al.. (2014). A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange. Transfusion and Apheresis Science. 52(2). 194–198. 25 indexed citations
19.
Erkurt, Mehmet Ali, İrfan Kuku, Emın Kaya, et al.. (2013). Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia. Transfusion and Apheresis Science. 48(3). 335–339. 11 indexed citations
20.
Erkurt, Mehmet Ali, Emın Kaya, İlhami Berber, Mustafa Köroğlu, & İrfan Kuku. (2012). Thrombocytopenia in Adults: Review Article. 1. 44–53. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026